Literature DB >> 8306093

Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.

S Yamanaka1, H Iwao, T Yukimura, S Kim, K Miura.   

Abstract

1. The present study was conducted in order to examine the effects of the platelet-activating factor (PAF) antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the acute haemodynamic responses to endotoxin in anaesthetized dogs. 2. Endotoxin (2 mg kg-1, i.v.) induced a severe hypotension by decreasing both total peripheral resistance (TPR) and cardiac output. Endotoxin also decreased central venous pressure and increased effective vascular compliance (EVC), indicating a blood pooling in the capacitance vessels. 3. The endotoxin-induced hypotension but not the fall in cardiac output, was markedly attenuated by ibuprofen. Ibuprofen abolished the decrease in TPR and even caused a systemic vasoconstriction. Ibuprofen abolished the increase in EVC. 4. The hypotension caused by endotoxin was attenuated by TCV-309 to a lesser extent than ibuprofen. However, the reduction in cardiac output produced by endotoxin was markedly attenuated by the PAF antagonist. TCV-309 also abolished the increase in EVC. In contrast to ibuprofen, TCV-309 did not affect the decrease in TPR caused by endotoxin. 5. Combined treatment with ibuprofen and TCV-309 markedly attenuated the endotoxin-induced hypotension, but not the fall in cardiac output. Nevertheless, when compared with animals treated with ibuprofen alone, treatment with ibuprofen and TCV-309 partly attenuated the endotoxin-induced reduction in cardiac output and systemic vasoconstriction. 6. These data indicate that dilatation of both resistance vessels and capacitance vessels contributes to the endotoxin-induced hypotension. It is suggested that (i) both prostanoids and PAF are involved in dilatation of capacitance vessels, (ii) prostanoids, but not PAF cause dilatation of resistance vessels and(iii) PAF may partly contribute to prostanoid-independent reduction in cardiac output in acute canine experimental endotoxin shock.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8306093      PMCID: PMC2175868          DOI: 10.1111/j.1476-5381.1993.tb13992.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Contribution of peripheral blood pooling to central hemodynamic disturbances during endotoxin insult in intact dogs.

Authors:  V D'Orio; C Wahlen; M Naldi; A Fossion; J Juchmes; R Marcelle
Journal:  Crit Care Med       Date:  1989-12       Impact factor: 7.598

Review 2.  Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock.

Authors:  M Sánchez Crespo; S Fernández-Gallardo
Journal:  J Lipid Mediat       Date:  1991 Sep-Oct

3.  A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia.

Authors:  J M Moore; M A Earnest; A G DiSimone; N N Abumrad; J R Fletcher
Journal:  Circ Shock       Date:  1991-09

4.  Preferential venoconstriction by cyclooxygenase inhibition in vivo without attenuation of nitroglycerin venodilation.

Authors:  T Münzel; D J Stewart; J Holtz; E Bassenge
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

5.  Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway.

Authors:  G Julou-Schaeffer; G A Gray; I Fleming; C Schott; J R Parratt; J C Stoclet
Journal:  Am J Physiol       Date:  1990-10

6.  Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo.

Authors:  C Thiemermann; J Vane
Journal:  Eur J Pharmacol       Date:  1990-07-17       Impact factor: 4.432

7.  Prostaglandins mediate skeletal muscle arteriole dilation in hyperdynamic bacteremia.

Authors:  H G Cryer; R N Garrison; P D Harris; B H Greenwald; N L Alsip
Journal:  Am J Physiol       Date:  1990-09

8.  Portal venous compliance in canine endotoxin shock.

Authors:  F L Abel; R R Beck
Journal:  Circ Shock       Date:  1991-10

9.  Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins.

Authors:  K Miura; T Yukimura; Y Yamashita; T Shimmen; M Okumura; S Yamanaka; M Imanishi; K Yamamoto
Journal:  J Pharmacol Exp Ther       Date:  1991-01       Impact factor: 4.030

10.  NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock.

Authors:  R E Klabunde; R C Ritger
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

View more
  3 in total

Review 1.  Cardiac dysfunction in sepsis: new theories and clinical implications.

Authors:  R M Grocott-Mason; A M Shah
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

2.  Comparative study of endotoxin-induced hypotension in kininogen-deficient rats with that in normal rats.

Authors:  A Ueno; H Ishida; S Oh-ishi
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

3.  Effects of ibuprofen on the physiology and outcome of rabbit endotoxic shock.

Authors:  Ilhami Celik; Ayhan Akbulut; S Sirri Kilic; Ali Rahman; Pervin Vural; Mukaddes Canbaz; Suleyman Felek
Journal:  BMC Infect Dis       Date:  2002-10-31       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.